1 |
He F, Deng Y, Li W. Coronavirus disease 2019: What we know? [J]. J Med Virol, 2020, 92(7): 719-725.
|
2 |
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J]. Lancet, 2020, 395(10223): 507-513.
|
3 |
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J]. Lancet, 2020, 395(10223): 497-506.
|
4 |
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [J]. JAMA, 2020, 323(11): 1061-1069.
|
5 |
Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [J]. JAMA, 2020 Feb 24. [Epub ahead of print].
|
6 |
国家卫生健康委办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第七版) [EB/OL].
URL
|
7 |
李文雯, 万献尧. 对急性呼吸窘迫综合征柏林诊断标准中有关校正氧合指数计算公式的修正 [J]. 中华内科杂志, 2014, 58(8): 677.
|
8 |
Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) [J]. Crit Care Med, 2020, 48(6): e440-e469.
|
9 |
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome [J]. Lancet Respir Med, 2020, 8(4):420-422.
|
10 |
国务院联防联控机制新闻发布会. 新冠肺炎疫情防控与医疗诊治有关情况(2020年3月24日)[EB/OL].
URL
|
11 |
Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure [J]. N Engl J Med, 2015, 372(33):2185-2196.
|
12 |
Ni YN, Luo J, Yu H, et al. The effect of high flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis [J]. Am J Emerg Med, 2018, 36(2): 226-233.
|
13 |
Ou X, Hua Y, Liu J, et al. Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials [J]. CMAJ, 2017, 189(7): E260-E267.
|
14 |
Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta analysis [J]. Intensive Care Med, 2019, 45(5):563-572.
|
15 |
Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [J]. N Engl J Med, 2020, 382(19): 1787-1799.
|
16 |
Ferner RE, Aronson JK. Chloroquine and hydroxychloroquine in COVID-19 [J]. BMJ, 2020, 369: m1432.
|
17 |
Geleris J, Sun Y, Platt J, et al. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 [J]. N Engl J Med, 2020, 382(25): 2411-2418.
|
18 |
Tang W, Cao Z, Han M, et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial [J]. BMJ, 2020, 369: m1849.
|
19 |
Mehra MR, Desai SS, Frank Ruschitzka F, et al. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis [J]. Lancet, 2020, S0140-6736(20)31180-6.
|
20 |
Grein J, Ohmagari N, Shin D, et al. Compassionate Use of Remdesivir for patients with severe COVID-19 [J]. N Engl J Med, 2020, 382(24): 2327-2336.
|
21 |
Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial [J]. Lancet, 2020, 395(10236): 1569-1578.
|
22 |
Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19-Preliminary Report [J]. N Engl J Med, 2020, 173(2): JC4.
|
23 |
Lewis SR, Pritchard MW, Thomas CM, et al. Pharmacological agents for adults with acute respiratory distress syndrome [J]. Cochrane Database Syst Rev, 2019, 7(7): CD004477.
|
24 |
Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 pneumonia in Wuhan [J]. JAMA Intern Med, 2020, 180(7): 1-11.
|
25 |
Ong SWX, Tan YK, Chia PY, et al. Air, surface environmental, and personal protective equipment contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from a symptomatic patient [J]. JAMA, 2020, 323(16): 1610-1612.
|